Seizure suppression by GDNF gene therapy in animal models of epilepsy

Molecular Therapy

Volumn 15, Issue 6, 2007, Pages 1106-1113

  Kanter Schlifke, Irene ^a   Georgievska, Biljana ^b,c   Kirik, Deniz ^b   Kokaia, Merab ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b LUND UNIVERSITY   (Sweden)

^c ASTRAZENECA R AND D   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; PARVOVIRUS VECTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTICONVULSANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; EPILEPTIC STATE; GENE OVEREXPRESSION; GRAND MAL SEIZURE; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; INJECTION; KINDLING; MALE; NONHUMAN; RAT; TEMPORAL LOBE EPILEPSY; VIRAL GENE THERAPY; VIRUS RECOMBINANT;

ANIMALIA; RATTUS;

EID: 34249285188     PISSN: 15250016     EISSN: 15250024     Source Type: Journal    
DOI: 10.1038/sj.mt.6300148     Document Type: Article

References (50)

1. Treanor, JJ, Goodman, L, de Sauvage, F, Stone, DM, Paulsen, KT, Beck, CD et al. (1996). Characterization of a multicomponent receptor for GDNF. Nature 382: 80-83.
2. Lin, LF, Doherty, DH, Lile, JD, Bektesh, S and Collins, F (1993). GDNF: a glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons. Science 260: 1130-1132.
3. Arenas, E, Trupp, M, Akerud, P and Ibanez, CF (1995). GDNF prevents degeneration and promotes the phenotype of brain noradrenergic neurons in vivo. Neuron 15: 1465-1473.
4. Henderson, CE, Phillips, HS, Pollock, RA, Davies, AM, Lemeulle, C, Armanini, M et al. (1994). GDNF: A potent survival factor for motoneurons present in peripheral nerve and muscle. Science 266 1062-1064.
5. Hudson, J, Granholm, AC, Gerhardt, GA, Henry, MA, Hoffman, A, Biddle, P et al. (1995). Glial cell line-derived neurotrophic factor augments midbrain dopaminergic circuits in vivo. Brain Res Bull 36: 425-432.
6. Bourque, MJ and Trudeau, LE (2000). GDNF enhances the synaptic efficacy of dopaminergic neurons in culture. Eur J Neurosci 12: 3172-3180.
7. Wang, CY, Yang, F, He, X, Chow, A, Du, J, Russell, JT et al. (2001). Ca(2+) binding protein frequenin mediates GDNF-induced potentiation of Ca(2+) channels and transmitter release. Neuron 32: 99-112.
8. Choi-Lundberg, DL, Lin, Q, Chang, YN, Chiang, YL, Hay, CM, Mohajeri, H et al. (1997). Dopaminergic neurons protected from degeneration by GDNF gene therapy. Science 275: 838-841.
9. Harvey, BK, Chang, CF, Chiang, YH, Bowers, WJ, Morales, M, Hoffer, BJ et al. (2003). HSV amplicon delivery of glial cell line-derived neurotrophic factor is neuroprotective against ischemic injury. Exp Neurol 183: 47-55.
10. Lu, KW, Chen, ZY and Hou, TS (2004). Protective effect of liposome-mediated glial cell line-derived neurotrophic factor gene transfer in vivo on motoneurons following spinal cord injury in rats. Chin J Traumatol 7: 275-279.
11. Humpel, C, Hoffer, B, Stromberg, I, Bektesh, S, Collins, F and Olson, L (1994). Neurons of the hippocampal formation express glial cell line-derived neurotrophic factor messenger RNA in response to kainate-induced excitation. Neuroscience 59: 791-795.
12. Mikuni, N, Babb, TL, Chakravarty, DN and Christi, W (11999). Time course of transient expression of GDNF protein in rat granule cells of the bilateral dentate gyri after unilateral intrahippocampal kainic acid injection. Neurosci Lett 262: 215-218.
13. Schmidt-Kastner, R, Tomac, A, Hoffer, B, Bektesh, S, Rosenzweig, B and Olson, L (1994). Glial cell-line derived neurotrophic factor (GDNF) mRNA upregulation in striatum and cortical areas after pilocarpine-induced status epilepticus in rats. Brain Res Mol Brain Res 26: 325-30.
14. Reeben, M, Laurikainen, A, Hiltunen, JO, Castren, E and Saarma, M (1998). The messenger RNAs for both glial cell line-derived neurotrophic factor receptors, c-ret and GDNFRα, are induced in the rat brain in response to kainate-induced excitation. Neuroscience 83: 151-159.
15. Kokaia, Z, Airaksinen, MS, Nanobashvili, A, Larsson, E, Kujamaki, E, Lindvall, O et al. (1999). GDNF family ligands and receptors are differentially regulated after brain insults in the rat. Eur J Neurosci 11: 1202-1216.
16. Martin, D, Miller, G, Rosendahl, M and Russell, DA (1995). Potent inhibitory effects of glial derived neurotrophic factor against kainic acid mediated seizures in the rat. Brain Res 683: 172-178.
17. Li, S, Xu, B, Martin, D, Racine, RJ and Fahnestock, M (2002). Glial cell line-derived neurotrophic factor modulates kindling and activation-induced sprouting in hippocampus of adult rats. Exp Neurol 178: 49-58.
18. Yoo, YM, Lee, CJ, Lee, U and Kim, YJ (2006). Neuroprotection of adenoviral-vector-mediated GDNF expression against kainic-acid-induced excitotoxicity in the rat hippocampus. Exp Neurol 200: 407-417.
19. Ehrengruber, MU, Hennou, S, Bueler, H, Naim, HY, Deglon, N and Lundstrom, K (2001). Gene transfer into neurons from hippocampal slices: comparison of recombinant Semliki Forest Virus, adenovirus, adeno-associated virus, lentivirus, and measles virus. Mol Cell Neurosci 17: 855-871.
20. Larmet, Y, Reibel, S, Carnahan, J, Nawa, H, Marescaux, C and Depaulis, A (1995). Protective effects of brain-derived neurotrophic factor on the development of hippocampal kindling in the rat. Neuroreport 6 1937-1941.
21. Reibel, S, Vivien-Roels, B, Le, BT, Larmet, Y, Carnahan, J, Marescaux, C et al. (2000). Overexpression of neuropeptide Y induced by brain-derived neurotrophic factor in the rat hippocampus is long lasting. Eur J Neurosci 12: 595-605.
22. Xu, B, Michalski, B, Racine, RJ and Fahnestock, M (2004). The effects of brain-derived neurotrophic factor (BDNF) administration on kindling induction, Trk expression and seizure-related morphological changes. Neuroscience 126: 521-531.
23. Kokaia, M, Ernfors, P, Kokaia, Z, Elmer, E, Jaenisch, R and Lindvall, O (1995). Suppressed epileptogenesis in BDNF mutant mice. Exp Neurol 133: 215-224.
24. Scharfman, HE, Goodman, JH, Sollas, AL and Croll, SD (2002). Spontaneous limbic seizures after intrahippocampal infusion of brain-derived neurotrophic factor. Exp Neurol 174: 201-214
25. Bengzon, J, Kokaia, Z, Elmer, E, Nanobashvili, A, Kokaia, M and Lindvall, O (1997). Apoptosis and proliferation of dentate gyrus neurons after single and intermittent limbic seizures. Proc Natl Acad Sci USA 94: 10432-10437.
26. Parent, JM, Yu, TW, Leibowitz, RT, Geschwind, DH, Sloviter, RS and Lowenstein, DH (1997). Dentate granule cell neurogenesis is increased by seizures and contributes to aberrant network reorganization in the adult rat hippocampus. J Neurosci 17: 3727-3738.
27. Jakubs, K, Nanobashvili, A, Bonde, S, Ekdahl, CT, Kokaia, Z, Kokaia, M et al. (2006). Environment matters: Synaptic properties of neurons born in the epileptic adult brain develop to reduce excitability. Neuron 52: 1047-1059.
28. Francis, F, Koulakoff, A, Boucher, D, Chafey, P, Schaar, B, Vinet, MC et al. (1999). Doublecortin is a developmentally regulated, microtubule-associated protein expressed in migrating and differentiating neurons. Neuron 23: 247-256.
29. Mullen, RJ, Buck, CR and Smith, AM (1992). NeuN, a neuronal specific nuclear protein in vertebrates. Development 116: 201-211.
30. Kirik, D, Rosenblad, C, Bjorklund, A and Mandel, RJ (2000). Long-term rAAV-mediated gene transfer of GDNF in the rat Parkinson's model: intrastriatal but not intranigral transduction promotes functional regeneration in the lesioned nigrostriatal system. J Neurosci 20: 4686-4700.
31. Racine, RJ (1972). Modification of seizure activity by electrical stimulation. I. After-discharge threshold. Electroencephalogr Clin Neurophysiol 32: 269-279.
32. Mazarati, AM, Thompson, KW, Suchomelova, L, Sankar, R, Shirasaka, Y, Nissinen, J et al. (2006). Status epilepticus: Electrical stimulation models. In: Pitkanen, A, Schwartzkroin, PA and Moshe, SL (eds). Models of Seizures and Epilepsy. Elsevier Academic Press: London. pp. 449-464.
33. Dudek, FE, Clark S, Williams, PA and Grabenstatter, HL (2006). Kainate-induced status epilepticus: A chronic model of acquired epilepsy. In: Pitkanen, A, Schwartzkroin, PA and Moshe, SL (eds). Models of Seizures and Epilepsy. Elsevier Academic Press: London. pp. 415-432.
34. Serra, MP, Quartu, M, Mascia, F, Manca, A, Boi, M, Pisu, MG et al. (2005). Ret, GFRα-1, GFRα-2 and GFRα-3 receptors in the human hippocampus and fascia dentata. Int J Dev Neurosci 23: 425-438.
35. Burazin, TC and Gundlach, AL (1999). Localization of GDNF/neurturin receptor (c-ret, GFRα-1 and α-2) mRNAs in postnatal rat brain: differential regional and temporal expression in hippocampus, cortex and cerebellum. Brain Res Mol Brain Res 73: 151-71.
36. Chen, AC, Eisch, AJ, Sakai, N, Takahashi, M, Nestler, EJ and Duman, RS (2001). Regulation of GFRα-1 and GFRα-2 mRNAs in rat brain by electroconvulsive seizure. Synapse 39: 42-50.
37. Bonde, C, Sarup, A, Schousboe, A, Gegelashvili, G, Noraberg, J and Zimmer, J (2003). GDNF pre-treatment aggravates neuronal cell loss in oxygen-glucose deprived hippocampal slice cultures: A possible effect of glutamate transporter up-regulation. Neurochem Int 43: 381-388.
38. Liu, Z, Stafstrom, CE, Sarkisian, MR, Yang, Y, Hori, A, Tandon, P et al. (1997). Seizure-induced glutamate release in mature and immature animals: An in vivo microdialysis study. Neuroreport 8 2019-2023.
39. Zhang, WQ, Hudson, PM, Sobotka, TJ, Hong, JS and Tilson, HA (1991). Extracellular concentrations of amino acid transmitters in ventral hippocampus during and after the development of kindling. Brain Res 540: 315-318.
40. Liou, JC, Yang, RS and Fu, WM (1997). Regulation of quantal secretion by neurotrophic factors at developing motoneurons in Xenopus cell cultures. J Physiol 503: 129-139.
41. Pathos, EN, Davila, V and Sulzer, D (1998). Presynaptic recording of quanta from midbrain dopamine neurons and modulation of the quantal size. J Neurosci 18: 4106-4118.
42. Feng, L, Wang, CY, Jiang, H, Oho, C, Mizuno, K, Dugich-Djordjevic, M et al. (1999). Differential effects of GDNF and BDNF on cultured ventral mesencephalic neurons. Brain Res Mol Brain Res 66: 62-70.
43. Wang, J, Chen, G, Lu, B and Wi, CP (2003). GDNF acutely potentiates Ca2+ channels and excitatory synaptic transmission in midbrain dopaminergic neurons. Neurosignals 12: 78-88.
44. Korte, M, Carroll, P, Wolf, E, Brem, G, Thoenen, H and Bonhoeffer, T (1995). Hippocampal long-term potentiation is impaired in mice lacking brain-derived neurotrophic factor. Proc Natl Acad Sci USA 92 8856-8860.
45. Asztely, F, Kokaia, M, Olofsdotter, K, Ortegren, U and Lindvall, O (2000). Afferent-specific modulation of short-term synaptic plasticity by neurotrophins in dentate gyrus. Eur J Neurosci 12: 662-669.
46. Kokaia, M, Asztely, F, Olofsdotter, K, Sindreu, CB, Kullmann, DM and Lindvall, O (1998). Endogenous neurotrophin-3 regulates short-term plasticity at lateral perforant path-granule cell synapses. J Neurosci 18: 8730-8739.
47. Nanobashvili, A, Airaksinen, MS, Kokaia, M, Rossi, J, Asztely, F, Olofsdotter, K et al. (2000). Development and persistence of kindling epilepsy are impaired in mice lacking glial cell line-derived neurotrophic factor family receptor α 2. Proc Natl Acad Sci USA 97: 12312-12317.
48. Eslamboli, A, Georgievska, B, Ridley, RM, Baker, HF, Muzyczka, N, Burger, C et al. (2005). Continuous low-level glial cell line-derived neurotrophic factor delivery using recombinant adeno-associated viral vectors provides neuroprotection and induces behavioral recovery in a primate model of Parkinson's disease. J Neurosci 25: 769-777.
49. Mastakov, MY, Baer, K, Kotin, RM and During, MJ (2002). Recombinant adeno-associated virus serotypes 2- and 5-mediated gene transfer in the mammalian brain: Quantitative analysis of heparin co-infusion. Mol Ther 5: 371-380.
50. Racine, RJ (1972). Modification of seizure activity by electrical stimulation. II. Motor seizure. Electroencephalogr Clin Neurophysiol 32: 281-294.